These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27426453)

  • 21. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of impurity carryover and impurity profile in Febuxostat drug substance by LC-MS/MS technique.
    Kadivar MH; Sinha PK; Kushwah D; Jana P; Sharma H; Bapodra A
    J Pharm Biomed Anal; 2011 Dec; 56(4):749-57. PubMed ID: 21840659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Separation and structural elucidation of cefsulodin and its impurities in both positive and negative ion mode in cefsulodin sodium bulk material using liquid chromatography/tandem mass spectrometry.
    Ren X; Liu G; Tang K; Zhou P; Wang J
    Rapid Commun Mass Spectrom; 2021 Aug; 35(15):e9125. PubMed ID: 34000097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separation and characterization of impurities and isomers in cefpirome sulfate by liquid chromatography/tandem mass spectrometry and a summary of the fragmentation pathways of oxime-type cephalosporins.
    Ren X; Zhou J; Wang J
    Rapid Commun Mass Spectrom; 2021 Feb; 35(4):e9004. PubMed ID: 33188542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of the impurity profile and polymerized impurity in mezlocillin sodium by multiple heart-cutting two-dimensional liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
    Wang J; Zhou J; Xu Y; Zhu B; Li H
    Rapid Commun Mass Spectrom; 2019 Sep; 33(17):1410-1419. PubMed ID: 31148276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
    Vuletić M; Cindrić M; Koruznjak JD
    J Pharm Biomed Anal; 2005 Apr; 37(4):715-21. PubMed ID: 15797793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of itraconazole and its photodegradation products with kinetic evaluation by ultra-performance liquid chromatography/tandem mass spectrometry.
    Kryczyk A; Żmudzki P; Hubicka U
    Biomed Chromatogr; 2016 Nov; 30(11):1733-1743. PubMed ID: 27116708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
    Xu Y; Wang D; Zhu B; Tang L; Wang J
    J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of impurities in methotrexate drug substances using high-performance liquid chromatography coupled with a photodiode array detector and Fourier transform ion cyclotron resonance mass spectrometry.
    Wu CS; Tong YF; Wang PY; Wang DM; Wu S; Zhang JL
    Rapid Commun Mass Spectrom; 2013 May; 27(9):971-8. PubMed ID: 23592199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry.
    Wang D; Wynne C; Gu F; Becker C; Zhao J; Mueller HM; Li H; Shameem M; Liu YH
    Anal Chem; 2015 Jan; 87(2):914-21. PubMed ID: 25513708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of paliperidone photodegradation products by LC-Q-TOF multistage mass spectrometry.
    Skibiński R; Komsta Ł; Inglot T
    Biomed Chromatogr; 2016 Jun; 30(6):894-901. PubMed ID: 26400838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
    Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impurity profile study of cefalotin sodium by two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry].
    Qiu Y; Qin F; Wen H; Zhao J; Liu H; Yang M
    Se Pu; 2015 Dec; 33(12):1314-9. PubMed ID: 27097466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation and characterization of allergic polymerized impurities in cephalosporins by 2D-HPSEC×LC-IT-TOF MS.
    Xu Y; Wang D; Tang L; Wang J
    J Pharm Biomed Anal; 2017 Oct; 145():742-750. PubMed ID: 28806571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of impurities in dirithromycin by liquid chromatography/ion trap mass spectrometry.
    Diana J; Govaerts C; Hoogmartens J; Van Schepdael A; Adams E
    J Chromatogr A; 2006 Aug; 1125(1):52-66. PubMed ID: 16782117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of impurities of HIV NNRTI Doravirine by UHPLC-high resolution MS and tandem MS analysis.
    Zhang LK; Yang R; Sheng H; Helmy R; Zheng J; Cao Y; Gauthier DR
    J Mass Spectrom; 2016 Oct; 51(10):959-968. PubMed ID: 27383410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impurity profiling of capreomycin using dual liquid chromatography coupled to mass spectrometry.
    Chopra S; Pendela M; Hoogmartens J; Van Schepdael A; Adams E
    Talanta; 2012 Oct; 100():113-22. PubMed ID: 23141318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.